Agree with that elze. Sales will be dependent on international sales for 6 months so a few steps backwards temporarily it seems.
the upside after that 6 months though is now significantly large now that they have such a major manufacturing partner on board.
great time for the patient to accumulate a good holding at below fair value prices due to temporarily slow down until it grows more substantially then it was going to now with Foxconn on board .
6 months is not a long wait if the announcement of a rapidly growing China market comes to fruition.
in the meantime we hope for a big ehealth spirosonic deal or large 1a sales internationally
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.759M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500000 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 46000 | 1 |
View Market Depth
| Last trade - 16.21pm 26/06/2025 (20 minute delay) ? |
| UCM (ASX) Chart |
Day chart unavailable